OR WAIT null SECS
September 02, 2019
In this interview, the main uses and benefits of NIR spectroscopy in tableting are discussed.
Regulatory bodies are taking a more stringent approach to excipient quality, but unlike guidance on GMP for APIs, those for excipients offer a framework only, meaning the onus lies with the manufacturer or supplier.
August 02, 2019
A risk-based approach to CMC enables drug sponsors to focus on clinical and manufacturing development paths.
Instrumentation advancements over the past 30 years have certainly enabled greater efficiency in pharma development and analysis despite slow adoption by the industry.
To deal with the complex requirements of biopharmaceuticals, companies need a sophisticated toolbox of analytical and purification techniques.
July 30, 2019
Cambrex has revealed that it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland.
July 02, 2019
This article discusses current methods of endotoxin testing, its importance to the industry, sustainability issues relating to the process, and best practices.
April 30, 2019
Lonza’s SimpliFiH Services addresses bioavailability challenges with drug substance, solid-state characterization, and drug product for first-in-human studies.
April 02, 2019
Characterizing particles and understanding bulk powder behavior is critical to get the best pharma product.
Confidence in the quality systems and scientific competence of the API manufacturing team is essential.